• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

导管原位癌(DCIS)的异质性:分级和亚型分析与局部复发及浸润性转化风险的关系。

Heterogeneity of duct carcinoma in situ (DCIS): relationship of grade and subtype analysis to local recurrence and risk of invasive transformation.

作者信息

Lagios M D

机构信息

Cancer Consultation Service, St. Mary's Medical Center, San Francisco, CA, USA.

出版信息

Cancer Lett. 1995 Mar 23;90(1):97-102. doi: 10.1016/0304-3835(94)03683-a.

DOI:10.1016/0304-3835(94)03683-a
PMID:7720048
Abstract

Morphologic analysis of nuclear grade and extent of necrosis can provide reproducible classification of subclinical duct carcinoma in situ (DCIS) which strongly separates DCIS into three risk groups. For subclinical lesions of small size, risk is largely limited to local recurrences only, half of which, however, are invasive events. Local recurrences are seen much more frequently with high grade DCIS. Most local recurrences following breast conservation therapy represent residual disease in the immediate vicinity of the biopsy site. Stromal and cellular host reactions may provide additional prognostic information.

摘要

对核分级和坏死范围进行形态学分析,可为亚临床导管原位癌(DCIS)提供可重复的分类,该分类能有力地将DCIS分为三个风险组。对于小尺寸的亚临床病变,风险主要局限于局部复发,不过其中一半为浸润性事件。高级别DCIS的局部复发更为常见。保乳治疗后的大多数局部复发代表活检部位紧邻区域的残留疾病。基质和细胞宿主反应可能提供额外的预后信息。

相似文献

1
Heterogeneity of duct carcinoma in situ (DCIS): relationship of grade and subtype analysis to local recurrence and risk of invasive transformation.导管原位癌(DCIS)的异质性:分级和亚型分析与局部复发及浸润性转化风险的关系。
Cancer Lett. 1995 Mar 23;90(1):97-102. doi: 10.1016/0304-3835(94)03683-a.
2
Ductal carcinoma in situ. The success of breast conservation therapy: a shared experience of two single institutional nonrandomized prospective studies.导管原位癌。保乳治疗的成功:两项单机构非随机前瞻性研究的共同经验。
Surg Oncol Clin N Am. 1997 Apr;6(2):385-92.
3
Is there a low-grade precursor pathway in breast cancer?乳腺癌是否存在低度恶性前体途径?
Ann Surg Oncol. 2012 Apr;19(4):1115-21. doi: 10.1245/s10434-011-2053-0. Epub 2011 Sep 21.
4
Heterogeneity of ductal carcinoma in situ of the breast.乳腺导管原位癌的异质性
J Cell Biochem Suppl. 1993;17G:49-52.
5
Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.导管原位癌治疗后局部复发的预测因素:一项荟萃分析。
Cancer. 1999 Feb 1;85(3):616-28.
6
Prognostic classification of breast ductal carcinoma-in-situ.乳腺导管原位癌的预后分类
Lancet. 1995 May 6;345(8958):1154-7. doi: 10.1016/s0140-6736(95)90982-6.
7
Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast.
J Clin Oncol. 1998 Apr;16(4):1367-73. doi: 10.1200/JCO.1998.16.4.1367.
8
Ductal carcinoma in situ of the breast (DCIS) with heterogeneity of nuclear grade: prognostic effects of quantitative nuclear assessment.具有核分级异质性的乳腺导管原位癌(DCIS):定量核评估的预后影响
BMC Cancer. 2007 Sep 10;7:174. doi: 10.1186/1471-2407-7-174.
9
Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence.乳腺钼靶检查发现的导管原位癌。乳房局部切除术后局部复发的频率以及核分级对局部复发的预后影响。
Cancer. 1989 Feb 15;63(4):618-24. doi: 10.1002/1097-0142(19890215)63:4<618::aid-cncr2820630403>3.0.co;2-j.
10
Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy.仅通过活检治疗的乳腺低级别导管原位癌诊断后15至25年,癌灶持续局部复发。
Cancer. 1995 Oct 1;76(7):1197-200. doi: 10.1002/1097-0142(19951001)76:7<1197::aid-cncr2820760715>3.0.co;2-0.

引用本文的文献

1
The impact of the BreastScreen NSW transition from film to digital mammography, 2002-2016: a linked population health data analysis.2002 - 2016年新南威尔士州乳腺筛查从胶片乳腺摄影向数字乳腺摄影转变的影响:一项关联人口健康数据分析
Med J Aust. 2025 Feb 3;222(2):82-90. doi: 10.5694/mja2.52566. Epub 2025 Jan 12.
2
Morphological intratumor heterogeneity in ductal carcinoma in situ of the breast.乳腺导管原位癌的形态学肿瘤内异质性。
Virchows Arch. 2021 Jul;479(1):33-43. doi: 10.1007/s00428-021-03040-6. Epub 2021 Jan 27.
3
Derivation of a nuclear heterogeneity image index to grade DCIS.
用于对导管原位癌进行分级的核异质性图像指数的推导
Comput Struct Biotechnol J. 2020 Dec 3;18:4063-4070. doi: 10.1016/j.csbj.2020.11.040. eCollection 2020.
4
Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion study.乳腺导管原位癌术前二分类组织病理学评估的观察者间变异性:DCISion 研究。
Mod Pathol. 2020 Mar;33(3):354-366. doi: 10.1038/s41379-019-0367-9. Epub 2019 Sep 18.
5
Combined application of pharamcokinetic DCE-MRI and IVIM-DWI could improve detection efficiency in early diagnosis of ductal carcinoma in situ.联合应用药代动力学 DCE-MRI 和 IVIM-DWI 可提高导管原位癌早期诊断的检出效率。
J Appl Clin Med Phys. 2019 Jul;20(7):142-150. doi: 10.1002/acm2.12624. Epub 2019 May 23.
6
Computer-aided heterogeneity analysis in breast MR imaging assessment of ductal carcinoma in situ: Correlating histologic grade and receptor status.计算机辅助乳腺磁共振成像评估导管原位癌异质性分析:与组织学分级和受体状态的相关性。
J Magn Reson Imaging. 2017 Dec;46(6):1748-1759. doi: 10.1002/jmri.25712. Epub 2017 Apr 3.
7
Impact of Histopathological Factors, Patient History and Therapeutic Variables on Recurrence-free Survival after Ductal Carcinoma in Situ: 8-Year Follow-up and Questionnaire Survey.组织病理学因素、患者病史及治疗变量对导管原位癌无复发生存率的影响:8年随访及问卷调查
Geburtshilfe Frauenheilkd. 2016 Jan;76(1):46-52. doi: 10.1055/s-0041-110805.
8
Attacking breast cancer at the preinvasion stage by targeting autophagy.通过靶向自噬在侵袭前阶段攻克乳腺癌。
Womens Health (Lond). 2013 Mar;9(2):157-70. doi: 10.2217/whe.13.5.
9
Variable stromal periductular expression of CD34 and smooth muscle actin (SMA) in intraductal carcinoma of the breast.乳腺导管内癌中 CD34 和平滑肌肌动蛋白(SMA)的间质管周表达具有可变性。
PLoS One. 2013;8(3):e57773. doi: 10.1371/journal.pone.0057773. Epub 2013 Mar 1.
10
Down-regulation of ANAPC13 and CLTCL1: Early Events in the Progression of Preinvasive Ductal Carcinoma of the Breast.下调 ANAPC13 和 CLTCL1:乳腺癌前导管原位癌进展的早期事件。
Transl Oncol. 2012 Apr;5(2):113-23. doi: 10.1593/tlo.11280. Epub 2012 Apr 1.